| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.19 | 5e-08 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.21 | 9e-07 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.21 | 2e-06 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-05 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.16 | 6e-05 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.24 | 9e-05 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.23 | 0.0001 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0004 |